KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Shares Outstanding (2016 - 2025)

Novavax (NVAX) has 13 years of Shares Outstanding data on record, last reported at $86.8 million in Q4 2022.

  • For Q4 2022, Shares Outstanding rose 13.57% year-over-year to $86.8 million; the TTM value through Dec 2022 reached $86.8 million, up 13.57%, while the annual FY2022 figure was $86.8 million, 13.57% up from the prior year.
  • Shares Outstanding reached $86.8 million in Q4 2022 per NVAX's latest filing, up from $79.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $86.8 million in Q4 2022 and bottomed at $17.4 million in Q1 2018.
  • Average Shares Outstanding over 5 years is $52.7 million, with a median of $62.3 million recorded in 2020.
  • Peak YoY movement for Shares Outstanding: surged 160.74% in 2020, then increased 4.25% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $19.2 million in 2018, then skyrocketed by 68.35% to $32.4 million in 2019, then soared by 120.22% to $71.4 million in 2020, then increased by 7.12% to $76.4 million in 2021, then rose by 13.57% to $86.8 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $86.8 million in Q4 2022, $79.2 million in Q3 2022, and $78.8 million in Q2 2022.